P PRIMESTOCKFINDER.COM

WAFD Stock WaFd, Inc.

US · NasdaqGS
$29.46 -0.03% Prices as of close 2026-10-27

Last in our picks 2026-09-27 — not in the current list; analysis below is from that screen

Not a cybersecurity stock.

Future value: $37.25 (+18.82%) · 6-12 months · analyst consensus

  • ▸Not applicable.
  • ▾Below 50-day MA (-12.53%)
  • ▸Volume 2.11× average — accumulation

Trend: WAFD is trading below the 50-day average (-9.24%), RSI 38 — neutral momentum, with a 3-month return of -19.73%.

Valuation & quality: WaFd, Inc. trades on a trailing P/E of 9.2, forward P/E 7.3, PEG 1.85, price-to-book 0.81; fundamentals show net margin 33.0%, return on equity 8.5%, revenue growth 8.2% year on year.

Analyst consensus: 4 analysts have a mean 12-month price target of $31.75 (+7.8% vs the last close; range $31.00 – $34.00), consensus rating “hold”.

Income: trailing dividend yield 3.66%.

Our screen: ACCUMULATE (score 1) — Not a cybersecurity stock.

Computed from end-of-day data; not personal advice.

39.3 28.4 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-09 → 2026-10-26 (USD). Range 28.4 – 39.3.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+0.80%+12.70%+0.50%+7.90%-4.20%-2.70%-16.30%-1.60%
Market cap
$2.18B
P/E (ttm)
9.2
Forward P/E
7.3
EPS (ttm)
$3.21
Price / book
0.81
PEG
1.85
Beta
0.88
Net margin
33.0%
ROE
8.5%
Revenue growth
8.2%
Earnings growth
5.3%
Revenue (ttm)
$776.2M
Dividend yield
3.66%
52-wk range
$28.10 – $39.49
Volume
728,045
Avg volume (3m)
948,835
Mean target
$31.75
Low
$31.00
High
$34.00
Analysts
4
Consensus
HOLD
RSI (14)
37.8
vs 50-day MA
-9.24%
1-mo return
-6.03%
3-mo return
-19.73%
Volume z-score
-0.58

WaFd, Inc. operates as the bank holding company for Washington Federal Bank that provides lending, depository, insurance, and other banking services in the United States.

Sector: Financial Services · Industry: Banks - Regional · United States · 2,014 employees · Website

Browse: all US stocks · Cybersecurity picks · today's movers

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.